Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab) [Phase 4]
A Phase 4 clinical trial evaluating differences in cell-derived microparticles in patients with psoriasis treated with ustekinumab (Stelara)…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment [Phase 4]
This Phase 4 clinical trial update reports on quality-of-life outcomes in psoriasis patients treated with ustekinumab, with results posted i…
-
FDA approval · 2016-02-05FDA Approved: TACLONEX — Supplemental Application (LEO Pharma Inc.)
The FDA approved a supplemental application for TACLONEX (calcipotriene and betamethone dipropionate) from LEO Pharma Inc., resulting in upd…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects [Phase 2]
A completed Phase 2 multiple-dose study of AMG 714 in adults with moderate to severe psoriasis has been completed.
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept [Phase 4]
Phase 4 clinical trial update evaluating two management strategies for subjects with plaque psoriasis who responded to etanercept; results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients [Phase 2]
Phase 2 trial evaluating a 12-month treatment with secukinumab in plaque psoriasis. The study assessed skin response and biomarkers and is r…
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis [Phase 3]
This clinical trial update reports a Phase 3 study evaluating the efficacy and safety of metformin for moderate psoriasis. The study status …
-
FDA approval · 2015-12-23FDA Approved: ACITRETIN — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal Pharmaceuticals of New York LLC's generic acitretin for oral use under Original Application (ANDA 202552).
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
A completed clinical trial evaluating cardiovascular risk in patients with severe psoriasis treated with biologic agents.
-
CLINICAL_TRIALS research · 2015-12-21Clinical Trial Update: Pilot Study Characterizing Adipose Tissue Leukocytes by Flow Cytometry/Microscopy in Lean, Obese and Psoriatic Subjects
The clinical trial NCT01856647 evaluating adipose tissue leukocytes by flow cytometry and microscopy in lean, obese, and psoriatic subjects …
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Clinical Assessment and Psychosocial Impact of Psoriasis
A completed clinical trial assessing clinical outcomes and the psychosocial impact of psoriasis.
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 trial of BMS-582949 for moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis. [Phase 4]
A Phase 4 clinical trial evaluating sequential treatment with Daivobet (betamethasone dipropionate plus calcipotriol) followed by Daivonex (…
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Tofacitinib Ointment For Chronic Plaque Psoriasis [Phase 2]
Pfizer-conducted Phase 2 trial evaluating topical tofacitinib ointment for chronic plaque psoriasis has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2015-11-23Clinical Trial Update: Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis [Phase 2]
Phase 2 trial assesses the efficacy of adjunctive atorvastatin for chronic plaque psoriasis; results were posted after completion in 2015.
-
FDA approval · 2015-11-23FDA Approved: CLOBETASOL PROPIONATE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' generic clobetasol propionate topical product under an Original Application (ANDA 206075).
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Blue Light for Treating Psoriasis Vulgaris [NA]
A completed clinical trial evaluated blue light therapy for psoriasis. Results were posted in November 2015.
-
CLINICAL_TRIALS withdrawal · 2015-11-17Clinical Trial Update: Influence of Atorvastatin on Psoriasis Severity and Endothelial Function [Phase 3]
A Phase 3 trial examining atorvastatin for psoriasis severity and endothelial function has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis [NA]
This update reports on a completed clinical trial evaluating the effect of vitamin D supplementation on metabolic parameters in patients wit…
-
FDA approval · 2015-10-16FDA Approved: ENSTILAR — Original Application (LEO Pharma Inc.)
FDA approved ENSTILAR, a fixed-dose topical combination of calcipotriene and betamethasone dipropionate for psoriasis.
-
FDA approval · 2015-10-06FDA Approved: ACITRETIN — Supplemental Application (Sigmapharm Laboratories, LLC)
The FDA approved a supplemental application for Acitretin from Sigmapharm Laboratories, LLC. The approval updates the regulatory status of A…
-
FDA approval · 2015-09-10FDA Approved: ACITRETIN — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves an Original Application for ACITRETIN (acitretin) from Mylan Pharmaceuticals Inc., a generic for the treatment of psoriasis and…
-
FDA approval · 2015-09-02FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved the original application for a generic fluocinonide acetonide topical product by Lupin Pharmaceuticals (ANDA 206422).
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis [Phase 3]
Phase 3 trial update on M518101 for plaque psoriasis; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With Psoriasis [Phase 1]
The document reports the completion of a Phase 1 clinical trial evaluating the safety, pharmacokinetics, and pharmacodynamics of UCB4940 in …